Psy118 - Resource Use Among Biological Therapy Initiators With Crohn’s Disease in Finland

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2693
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Accumulation of Hospital Days Among Antipsychotic Initiators With Alzheimer's Disease

Journal of the American Medical Directors Association
MedicineHealth PolicyGerontologyGeriatricsNursing
2019English

Safety Profile of Biologic Therapy in Polish Paediatric Patients With Crohn’s Disease

Przeglad Gastroenterologiczny
Gastroenterology
2015English

Natural History of Bleeding and Characteristics of Early Bleeders Among Warfarin Initiators &Ndash; A Cohort Study in Finland

Clinical Epidemiology
Epidemiology
2016English

Regulatory T-Cell Therapy in Crohn’s Disease: Challenges and Advances

Gut
Gastroenterology
2020English

Persistence, Dose Titration, and Health Care Resource Utilization Among Crohn’s Disease Patients Treated With Ustekinumab: A Real-World Analysis in the United States

Advances in Therapy
MedicinePharmacology
2020English

Individualized Treatment With Infliximab Therapy in Children With Crohn’s Disease Support Shorter Time Intervals Between Infusions

Journal of Drug Assessment
2012English

Does the Real-World Use of Pharmacological Therapy Follow Guidelines in Coronary Artery Disease Patients in Finland?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Self-Reported Antenatal Adherence to Medical Treatment Among Pregnant Women With Crohn’s Disease

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2010English

PWE-117 Have Perianal Surgery Rates Decreased With the Rise in Thiopurine Use in Crohn’s Disease?

Gut
Gastroenterology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy